Showing results (631-640 of 834) with videos related to
Sort By:
Pageof 84
Diabetes, Obesity & Metabolism|December 9, 2022
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trialNiels H Brandt-Jacobsen, Mikkel Jürgens, Philip Hasbak, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J L Heerspink, Bergur V Stefansson, Glenn M Chertow, et al.Journal of the American Heart Association|April 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD TrialGlenn M Chertow, Ricardo Correa-Rotter, Priya Vart, et al.Diabetes & Vascular Disease Research|May 22, 2016
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristicsPeter Godsk Jørgensen, Magnus T Jensen, Rasmus Mogelvang, et al.Frontiers in Nutrition|February 27, 2023
Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover studyHelena Zander Wodschow, Filip Søskov Davidovski, Jacob Christensen, et al.Kidney International|November 11, 2022
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetesGeorge L Bakris, Luis M Ruilope, Stefan D Anker, et al.Diabetes|January 21, 2022
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE TrialEmil Wolsk, Mikkel Jürgens, Morten Schou, et al.Clinical Kidney Journal|February 24, 2023
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetesJens Christian Laursen, Niels Søndergaard-Heinrich, Bryan Haddock, et al.BMJ Open|March 20, 2024
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trialsShweta Bansal, Maria E F Canziani, Rita Birne, et al.The New England Journal of Medicine|April 1, 2009
Rosuvastatin and cardiovascular events in patients undergoing hemodialysisBengt C Fellström, Alan G Jardine, Roland E Schmieder, et al.Pageof 84